Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Guangdong Association of Clinical Trials
Novartis
Novartis
Pfizer
The Affiliated Hospital of Qingdao University
AstraZeneca
On Target Laboratories, LLC
Shanghai Pulmonary Hospital, Shanghai, China
Charite University, Berlin, Germany
George Washington University
Vanderbilt-Ingram Cancer Center
Tongji Hospital
Institut Paoli-Calmettes